1AI-enabled
precision medicine
precision medicine
Bringing the power of data and artificial intelligence to healthcare.
With the power of AI, we
now have the ability to
now have the ability to
the discovery of novel targets
ACCELERATE
PREDICT
the effectiveness of treatments
potentially life-saving clinical trials
IDENTIFY
DIAGNOSE
multiple diseases earlier
Contract Address:
9RdydrZNRHgYrkArRkSQYNCNcyqTFwhWZspotdACpump
Discover our innovative technology
Nature Biotechnology Study Reveals that Tempus’ xT Platform Increases Cancer Patients’ Personalized Therapeutic Opportunities
Extensive molecular profiling combined with clinical data identifies targeted therapies and clinical trials for a large proportion of cancer patients, and paired tumor/normal plus transcriptome sequencing outperforms tumor-only DNA panel testing.
Through our scientific publications and research projects, we are accelerating and transforming personalized patient care.
Our Science
Actionable variants would have been missed if only solid tumor or liquid biopsy tests were performed. Thus, we believe that liquid biopsies provide value to patients when used in combination with standard tissue genotyping.
Validation of a Liquid Biopsy Assay with Molecular and Clinical Profiling of Circulating Tumor DNA
Showcasing a robust pan-cancer tumor organoid (TO) platform, revealing genomic/transcriptome fidelity of TO culture from >1,000 patients. We demonstrate a neural-network-based high-throughput approach for label-free,light-microscopy-based drug assays capable of predicting patient-specific heterogeneity in drug responses with applicability across solid cancers.
A Pan-cancer Organoid Platform for Precision Medicine and paired tumor/normal plus transcriptome sequencing
We can help patients find their own unique and optimal therapy options.
We can help physicians make more informed treatment decisions.
We can assist pharmaceutical and biotech companies with better drug development.
Explore Tecway
We can assist pharmaceutical and biotech companies with better drug development.
We can help physicians make more informed treatment decisions.
We can help patients find their own unique and optimal therapy options.
Explore Tecway
We can help patients find their own unique and optimal therapy options.
Explore Tecway
50%+
of oncologists in the US connected to Tempus through sequencing, clinical trial matching, and research-enabled partnerships
of the top 20 pharma oncology companies partner with Tempus
95%
30,000+
patients have been identified for potential enrollment into clinical trials in our network
petabytes of data
200+
of all Academic Medical Centers in the US are connected to Tempus
~65%
de-identified research records to power scientific discovery to improve patient outcomes
~7,000,000
200+
biopharma partnerships
Improving patient care through high quality testing, clinical trial matching, and deep research data that powers scientific discovery
